Carestream announced today that it has recapitalized its balance sheet and is well positioned for future growth. Carestream evaluated various strategic alternatives earlier this year. Due to the company's strong performance and attractive future prospects, Onex (TSX: OCX) and Carestream's Board of Directors chose to refinance the company's debt and continue to invest in long-term growth. 
Agfa HealthCare, a leading provider of enterprise clinical imaging and IT solutions, announces the global release for sale of ICIS(TM) View 3.0, the medical images and results viewer for the comprehensive ICIS enterprise imaging solution. The ICIS patient imaging data platform is a fundamental part of the company's global e-health strategy. Carestream has again earned a top rating against major competitors for its digital X-ray systems that are based on its proven wireless DRX technology. As reported by KLAS in its just published "Digital X-Ray Performance 2013 - Impact of a Wireless Workflow," the company's CARESTREAM DRX-Evolution scored highest for overall performance. Agfa HealthCare announces that its German operations, Agfa HealthCare GmbH, have been ranked 8th in the 2012 edition of the well-known Lünendonk Listing of the top 25 software companies in Germany. The increased ranking is partly based on the company's annual revenue. In the same timeframe, the number of employees at Agfa HealthCare GmbH increased from 701 to 742. The appointment in 2012 of Tromp Medical as distributor of Carestream Digital Capture Products across The Netherlands has led to an explosion in sales of Carestream's DRX-portfolio of digital radiography solutions. Over the past six months Tromp Medical has secured sales of 26 CARESTREAM DRX-Revolution Mobile X-ray Systems, 7 CARESTREAM DRX-Mobile Retrofit Kits, 2 CARESTREAM DRX-Ascend Systems and 5 of the new smaller format CARESTREAM DRX 2530C Detector for paediatric X-ray imaging. 
A collaboration between IBM and the National Cancer Institute of Milan has been using genomics and analytics technology to improve the treatment of rare tumors, sarcomas and cancers of the head and neck. The research, which is already showing signs of success, was awarded a prestigious prize by the Politecnico di Milan University in Lombardy, Italy.